XML 25 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Apr. 30, 2021
Cash flows from operating activities      
Net loss $ (236,161,000) $ (203,848,000) $ (129,434,000)
Adjustments to reconcile net loss to cash provided by operating activities:      
Depreciation and amortization 20,233,000 19,728,000 17,237,000
Investment Income, Net, Amortization of Discount and Premium (772,000) 0 0
Amortization of deferred contract acquisition costs 68,900,000 60,738,000 40,991,000
Amortization of debt issuance costs 1,023,000 803,000 0
Non-cash operating lease cost 10,880,000 8,636,000 7,927,000
Asset impairment charges 6,242,000 0 0
Stock-based compensation expense, net of amounts capitalized 204,039,000 140,612,000 93,680,000
Deferred income taxes (2,007,000) (2,430,000) 33,000
Foreign currency transaction (gain) loss 1,386,000 (1,984,000) 9,507,000
Other 44,000 98,000 (142,000)
Changes in operating assets and liabilities:      
Accounts receivable, net (46,353,000) (62,187,000) (24,037,000)
Deferred contract acquisition costs (102,017,000) (96,755,000) (81,137,000)
Prepaid expenses and other current assets 1,323,000 (3,427,000) (4,192,000)
Other assets 8,525,000 825,000 (4,107,000)
Accounts payable 6,304,000 21,036,000 (4,775,000)
Accrued expenses and other liabilities 4,310,000 27,192,000 8,118,000
Accrued compensation and benefits 8,324,000 17,775,000 3,867,000
Operating lease liabilities (11,405,000) (8,888,000) (7,914,000)
Deferred revenue 95,616,000 83,780,000 115,937,000
Net cash provided by operating activities 35,662,000 5,672,000 22,545,000
Cash flows from investing activities      
Purchases of property and equipment (2,684,000) (2,485,000) (3,912,000)
Capitalization of internal-use software 0 (4,932,000) (317,000)
Other 0 0 2,711,000
Net cash used in investing activities (272,952,000) (127,271,000) (1,518,000)
Cash flows from financing activities      
Proceeds from Issuance of Senior Long-term Debt 0 575,000,000 0
Proceeds from issuance of ordinary shares upon exercise of stock options 17,471,000 36,410,000 77,258,000
Payments of Debt Issuance Costs 0 (9,283,000) 0
Net cash provided by financing activities 17,471,000 602,127,000 77,258,000
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 2,822,000 (20,599,000) 6,034,000
Net increase (decrease) in cash, cash equivalents, and restricted cash (216,997,000) 459,929,000 104,319,000
Cash, cash equivalents, and restricted cash, beginning of period 863,637,000    
Cash, cash equivalents, and restricted cash, end of period 646,640,000 863,637,000  
Supplemental disclosures of cash flow information      
Interest Paid, Excluding Capitalized Interest, Operating Activities 24,136,000 12,995,000 0
Cash paid (refunds) for income taxes, net 11,581,000 3,979,000 (423,000)
Cash paid for operating lease liabilities 13,136,000 10,101,000 8,957,000
Supplemental disclosures of non-cash investing and financing information      
Property and equipment included in accounts payable 121,000 150,000 10,000
Operating lease right-of-use assets for new lease obligations 10,902,000 8,992,000 1,120,000
Acquisition-related indemnity holdback 0 6,000,000 0
Payments to Acquire Businesses, Net of Cash Acquired 0 (119,854,000) 0
Payments to Acquire Marketable Securities 270,268,000 0 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $ 646,640,000 $ 863,637,000 $ 403,708,000